Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical practice guidelines of the Catalan Society of Gastroenterology about hepatic elastography 2022.
Carrión JA, Graupera I, Vergara M, Morillas RM, Pericàs JM, Poca M, Amador A, Fernández R, Monllor T, Muñoz L, Bartres C, Genescà J, Ginés P, Forns X. Carrión JA, et al. Among authors: pericas jm. Gastroenterol Hepatol. 2023 Nov;46(9):732-746. doi: 10.1016/j.gastrohep.2022.11.005. Epub 2022 Nov 23. Gastroenterol Hepatol. 2023. PMID: 36435378 Free article. English, Spanish.
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes.
Rivera-Esteban J, Pons M, Planas A, Manzano-Nuñez R, Hernández C, Simó-Servat O, Bañeras J, Soler MJ, Seron D, Boixadera A, Augustin S, Simó R, Ferreira-González I, Genescà J, Pericàs JM; PRECISED consortium. Rivera-Esteban J, et al. Among authors: pericas jm. Gastroenterol Hepatol. 2023 Nov;46(9):682-691. doi: 10.1016/j.gastrohep.2022.11.001. Epub 2022 Nov 23. Gastroenterol Hepatol. 2023. PMID: 36435379 English, Spanish.
Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
Graupera I, Thiele M, Ma AT, Serra-Burriel M, Pich J, Fabrellas N, Caballeria L, de Knegt RJ, Grgurevic I, Reichert M, Roulot D, Schattenberg JM, Pericas JM, Angeli P, Tsochatzis EA, Guha IN, Garcia-Retortillo M, Morillas RM, Hernández R, Hoyo J, Fuentes M, Madir A, Juanola A, Soria A, Juan M, Carol M, Diaz A, Detlefsen S, Toran P, Pera G, Fournier C, Llorca A, Newsome PN, Manns M, de Koning HJ, Serra-Burriel F, Cucchietti F, Arslanow A, Korenjak M, van Kleef L, Falcó JL, Kamath PS, Karlsen TH, Castera L, Lammert F, Krag A, Ginès P; LiverScreen Consortium investigators. Graupera I, et al. Among authors: pericas jm. BMC Public Health. 2023 May 22;23(1):923. doi: 10.1186/s12889-023-15867-6. BMC Public Health. 2023. PMID: 37217864 Free PMC article. No abstract available.
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis.
Zheng K, Hao F, Medrano-Garcia S, Chen C, Guo F, Morán-Blanco L, Rodríguez-Perales S, Torres-Ruiz R, Peligros MI, Vaquero J, Bañares R, Gómez Del Moral M, Regueiro JR, Martínez-Naves E, Mohamed MR, Gallego-Durán R, Maya D, Ampuero J, Romero-Gómez M, Gilbert-Ramos A, Guixé-Muntet S, Fernández-Iglesias A, Gracia-Sancho J, Coll M, Graupera I, Ginès P, Ciudin A, Rivera-Esteban J, Pericàs JM, Frutos MD, Ramos Molina B, Herranz JM, Ávila MA, Nevzorova YA, Fernández-Malavé E, Cubero FJ. Zheng K, et al. Among authors: pericas jm. Cell Death Dis. 2023 Aug 10;14(8):514. doi: 10.1038/s41419-023-06029-y. Cell Death Dis. 2023. PMID: 37563155 Free PMC article.
Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells.
Gil M, Khouri L, Raurell I, Rafael D, Andrade F, Abasolo I, Schwartz S Jr, Martínez-Gómez M, Salcedo MT, Pericàs JM, Hide D, Wei M, Metanis N, Genescà J, Martell M. Gil M, et al. Among authors: pericas jm. Pharmaceutics. 2023 Oct 14;15(10):2463. doi: 10.3390/pharmaceutics15102463. Pharmaceutics. 2023. PMID: 37896223 Free PMC article.
Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study.
Rivera-Esteban J, Jiménez-Masip A, Muñoz-Martínez S, Augustin S, Guerrero RA, Gabriel-Medina P, Ferrer-Costa R, Rodríguez-Frías F, Turu E, Marco A, Pericàs JM, On Behalf Of The Prisonafld Study Group Collaborators. Rivera-Esteban J, et al. Among authors: pericas jm. J Clin Med. 2023 Nov 24;12(23):7276. doi: 10.3390/jcm12237276. J Clin Med. 2023. PMID: 38068330 Free PMC article.
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials.
Pericàs JM, Di Prospero NA, Anstee QM, Mesenbrinck P, Kjaer MS, Rivera-Esteban J, Koenig F, Sena E, Pais R, Manzano R, Genescà J, Tacke F, Ratziu V; EU-PEARL NASH Investigators. Pericàs JM, et al. Aliment Pharmacol Ther. 2023 May;57(9):948-961. doi: 10.1111/apt.17456. Epub 2023 Mar 14. Aliment Pharmacol Ther. 2023. PMID: 36918740 Review.
NAFLD as the metabolic hallmark of obesity.
Rojano A, Sena E, Manzano-Nuñez R, Pericàs JM, Ciudin A. Rojano A, et al. Among authors: pericas jm. Intern Emerg Med. 2023 Jan;18(1):31-41. doi: 10.1007/s11739-022-03139-x. Epub 2022 Nov 10. Intern Emerg Med. 2023. PMID: 36357606 Review.
211 results